Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.94
Delayed Data
As of May 05
 -0.31 / -3.76%
Today’s Change
3.79
Today|||52-Week Range
9.45
+48.41%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close8.25
Today’s open8.19
Day’s range7.88 - 8.25
Volume455,800
Average volume (3 months)628,661
Market cap$580.1M
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)-14.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+79.73%
P/E ratioNM
Price/Sales218.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.42-2.08%
VTLVital Therapies Inc-0.21-0.86%
XNCRXencor Inc-0.96-6.50%
TBPHTheravance Biopharma...-0.22-1.34%
Data as of 05/05/2015

Financials

Last reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.6M
Net profit margin-9,328.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers